As a result of the different event rates in the two studies, the median durations of follow-up were also substantially different (3.8 years in LEADER vs
Implications for employers : Employers should expect coverage of GLP-1 drugs for obesity to improve population health and employee productivity, but the return on investment from coverage is not likely to lead to lower medical costs now or in the future
A consultation with PlexusDx providerswho review your full medical history, genetic predispositions through optional Precision Peptide testing, and personal goalswill determine whether 0.25 semaglutide alone, progression to higher doses, or alternative compounds like oral semaglutide or tirzepatide better serve your objectives
Gut Barrier & Longevity Support Features Akkermansia postbiotic alongside targeted botanical polyphenols to help support gut lining integrity, metabolic health, and healthy aging as part of a balanced lifestyle.*
In particular, tell your provider if you have or had a past history of: Type 1 or type 2 diabetes Thyroid cancer Gastrointestinal disease Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
I've been using modern therapeutics to help people lose wight for two decades, longer before we had GLP1 medications